Cohen Klingenstein’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Cohen Klingenstein's ABBV Position: Q2 2026 in Review
Cohen Klingenstein held its AbbVie (ABBV) position steady in Q2 2026 at 18,000 shares worth $4.53M. The position accounts for 0.13% of the portfolio, ranked #75.
Cohen Klingenstein first reported a position in ABBV in Q2 2019 and has held it in 29 quarters since. The position peaked at $9.97M in Q3 2024. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cohen Klingenstein held 18,000 shares of AbbVie worth $4.53M as of Q2 2026.
- Cohen Klingenstein left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.13% of Cohen Klingenstein's portfolio in Q2 2026, its #75 holding.
- Cohen Klingenstein first reported a position in AbbVie in Q2 2019 and has held it in 29 quarters since.
- Cohen Klingenstein's AbbVie position peaked at $9.97M in Q3 2024.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.